Effect of immunogenicity on efficacy of long-term treatment of rheumatoid arthritis with adalimumab

Meghna Jani; Hector Chinoy; Richard B. Warren; Christopher Em Griffiths; Anne Barton

doi:10.1016/s0140-6736(14)60323-8

Related publications

Article2014

89. Influence of Immunogenicity on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab: A UK-Based Prospective Study

Meghna Jani, Hector Chinoy, Richard B. Warren, Christopher Em Griffiths, Ann W Morgan, Alison Wilson, Kimme L Hyrich, John D. Isaacs, Anne Barton

Article2014

SAT0052 Influence of Immunogenicity and Drug Levels on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab and Etanercept: A Uk-Based Prospective Study

Meghna Jani, Hector Chinoy, Richard B. Warren, Bo Fu, Christopher Em Griffiths, Ann W Morgan, G. M. Wilson, Kimme L Hyrich, John D. Isaacs, Anne Barton

Article2017

Long-term dietary quality and risk of developing rheumatoid arthritis in women

Yang Hu, Jeffrey A. Sparks, Susan Malspeis, Karen H. Costenbader, Frank B Hu, Elizabeth W. Karlson, Bing Lü

Article2015

Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis

Meghna Jani, Hector Chinoy, Richard B. Warren, Christopher Em Griffiths, Darren Plant, Ann W Morgan, Anthony G. Wilson, Kimme L Hyrich, John D. Isaacs, Anne Barton

Article2015

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

Meghna Jani, Hector Chinoy, Richard B. Warren, Christopher Em Griffiths, Darren Plant, Bo Fu, Ann W Morgan, Anthony G. Wilson, John D. Isaacs, Kimme L Hyrich, Anne Barton